Method of treating anxious major depressive disorder

Details Method of treating anxious major depressive disorder Method of treating anxious major depressive disorder

A - Human Necessities

61

K

A61K 31/495 (2006.01) A61P 25/22 (2006.01) A61P 25/24 (2006.01)

Patent

CA 2724955

The invention is directed to using 4-{(3-aminophenyl)[4-(4- fluorobenzyl)piperazin-1-yl]methyl}-N,N-diethylbenzamide, or enantiomer thereof, or pharmaceutically acceptable salt thereof, and/or mixture thereof to treat anxious major depressive disorder (AMDD).

L'invention concerne l'utilisation de 4-{(3-aminophényl)[4-(4-fluorobenzyl)pipérazin-1-yl]méthyl}-N,N-diéthylbenzamide, ou d'un énantiomère de celui-ci, ou d'un sel pharmaceutiquement acceptable de ces composés, et/ou d'un mélange de ceux-ci pour traiter un trouble dépressif majeur anxieux (TDMA).

Affiliated with

Also associated with

Rating

Method of treating anxious major depressive disorder does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Method of treating anxious major depressive disorder, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of treating anxious major depressive disorder will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1496351